###begin article-title 0
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
The purpose of this study is to analyze the combined effects of selected p53 and p73 polymorphisms and their interaction with lifestyle habits on squamous cell carcinoma of the head and neck (SCCHN) risk and progression in an Italian population.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 558 559 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Two hundred and eighty-three cases and 295 hospital controls were genotyped for p53 polymorphisms on exon 4 (Arg72Pro), intron 3 and 6, and p73 G4C14-to-A4T14. Their association with SCCHN was estimated using a logistic regression analysis, while a multinomial logistic regression approach was applied to calculate the effect of the selected polymorphisms on SCCHN different sites (oral cavity, oropharynx, hypopharynx and larynx). We performed an haplotype analysis of the p53 polymorphisms, and a gene-gene interaction analysis for the combined effects of p73 G4C14-to-A4T14 and p53 polymorphisms.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 590 591 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 484 491 <span type="species:ncbi:9606">persons</span>
We found a significant increased risk of SCCHN among individuals with combined p73 exon 2 G4A and p53 intron 3 variant alleles (OR = 2.22, 95% CI: 1.08-4.56), and a protective effect for those carrying the p53 exon 4-p53 intron 6 diplotype combination (OR = 0.67; 95% CI: 0.47-0.92). From the gene-environment interaction analysis we found that individuals aged < 45 years carrying p73 exon 2 G4A variant allele have a 12.85-increased risk of SCCHN (95% CI: 2.10-78.74) compared with persons of the same age with the homozygous wild type genotype. Improved survival rate was observed among p53 intron 6 variant allele carriers (Hazard Ratio = 0.51 (95% CI: 0.23-1.16).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Our study provides for the first time evidence that individuals carrying p53 exon 4 and p53 intron 6 variant alleles are significantly protected against SCCHN, and also shows that an additional risk is conferred by the combination of p73 exon 2 G4C14-to-A4T14 and p53 intron 3 variant allele. Larger studies are required to confirm these findings.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
Squamous cell carcinoma of the head and neck (SCCHN), including cancers of the oral cavity, pharynx and larynx, is one of the five most common cancers worldwide [1]. Epidemiological studies suggest a multifactorial aetiology, with smoking, alcohol drinking [2,3], oral HPV infection [4], low fruit and vegetables intake [5,6], and genetic factors playing a major role [7].
###end p 11
###begin p 12
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 325 326 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 561 562 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 971 972 971 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
The p53 protein, encoded by p53 tumor suppressor gene (17p13), is involved in cell-cycle regulation, DNA repair, inhibition of spontaneous mutations, and cellular differentiation and apoptosis [8]. The p53 gene is highly polymorphic, with at least 13 different polymorphisms described [9,10]. Some studies reported that rare p53 exon 4 - intron 3 - intron 6 haplotypes affect the frequency of mutation and loss of heterozygosity in B-lymphoblastoid cell lines, along with DNA repair and apoptosis [11,12]. Currently p53 exon 4 Arg72Pro polymorphism is the only p53 single nucleotide polymorphism (SNP) whose effect has been studied in relation to SCCHN, with conflicting results. Three studies conducted on Caucasians [13-15] reported the absence of a significant relationship between Pro variant allele and SCCHN, while Tsai et al [16] suggested an increased cancer risk for individuals carrying the variant allele in a Chinese population. Two intronic polymorphisms of p53 consisting of a 16-bp duplication in intron 3 and a G-A transition in intron 6, have been investigated in relation to lung, ovarian, breast and colon cancer, again with conflicting results [12,17-19]. To our knowledge, no one study thus far has investigated the effect of these two SNPs on SCCHN.
###end p 12
###begin p 13
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 798 799 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 135 140 <span type="species:ncbi:9606">human</span>
The p73 protein is a p53 homologue encoded by a polymorphic gene located on 1p36-33, mapping on a region often deleted in a variety of human cancers [20,21]. p73 protein activates several p53-responsive genes involved in cell cycle control, DNA repair and apoptosis, and inhibits cell growth in a p53-like manner by inducing apoptosis [22]. A p73 G4C14-to-A4T14 dinucleotide polymorphism has been reported to influence gene expression, and consists of two SNPs in complete linkage disequilibrium at positions 4 (G-A) and 14 (C-T) in the non-coding region of exon 2 [23]. Several studies investigated the relationship between the p73 G4C14-to-A4T14 polymorphism and cancer [10,24-27], among them the large study conducted by Li et al. reported an increased risk for SCCHN in Caucasians carrying the p73 G4C14-to-A4T14 variant genotype compared to GC/GC [10].
###end p 13
###begin p 14
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p53 </italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
To our knowledge, no one study investigated the influence of p53 intron 3 and 6 polymorphisms on SCCHN survival, while a poor disease-free survival has been reported in patients carrying the p53 exon4 Arg72Pro variant on SCCHN, lung, colorectal and breast cancer [28-31]. Lastly, a study reports an improved survival of colorectal cancer patients carrying the variant allele of p73 G4C14-to-A4T14 [32].
###end p 14
###begin p 15
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
The purpose of our study was to investigate the effects of p73 G4C14-to-A4T14 polymorphism and three p53-SNPs in exon 4 and introns 3 and 6, as well as their combination and their interaction with lifestyle habits, in association with SCCHN risk and progression within a hospital-based case-control study in an Italian population.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Study Population
###end title 17
###begin p 18
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 125 137 <span type="species:ncbi:9606">participants</span>
###xml 164 172 <span type="species:ncbi:9606">patients</span>
###xml 461 469 <span type="species:ncbi:9606">patients</span>
###xml 877 884 <span type="species:ncbi:9606">patient</span>
###xml 922 929 <span type="species:ncbi:9606">patient</span>
###xml 1132 1140 <span type="species:ncbi:9606">patients</span>
The study subjects were added to the age and gender matched sample of the previously published case-control study [5]. Study participants were recruited from among patients admitted to the teaching hospital "A. Gemelli" of the Universita Cattolica del Sacro Cuore (Rome, Italy) during the time period from May 2002 to May 2007, and eligibility was restricted to Caucasian individuals born in Italy. Cases were consecutive primary untreated head and neck cancer patients admitted to the Department of Otorhinolaryngology with histologically-confirmed squamous cell carcinoma of the head and neck (SCCHN). SCCHN diagnosis was defined according to the International Classification of Disease (9th revision, codes 140-149 and 161). Tumors were staged according to the UICC-TNM classification; 48.9% were staged I-II and 53.9% were classified T1-T2 (tumor stage was missing for one patient, and tumor grade was missing for one patient) [33]. Cases presented the following distribution according to tumor site: 67.7% laryngeal, 18.6% oral cavity, 6.5% oropharyngeal, and 8.2% hypopharyngeal. Controls were selected from among cancer-free patients admitted to the same hospital during the same time period with a broad range of diagnoses without matching to cases by any covariate. The study sample size comprised 283 cases and 295 controls, with a participation rate of 98% among cases and 93% among controls. Written informed consent was obtained from all study subjects, after which each subject provided a venous blood sample that was collected into EDTA-coated tubes. This study was performed according to the Declaration of Helsinki and was approved by the ethics committee of the Universita Cattolica del Sacro Cuore.
###end p 18
###begin title 19
Genotyping
###end title 19
###begin p 20
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 78 79 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 445 446 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
Genotyping for p53 intron 3 (rs17883323), p53 exon 4 codon 72 (rs1042522) and p53 intron 6 (rs1625895) polymorphisms were performed using a polymerase chain reaction (PCR) followed by restriction-fragment length polymorphism, as already described by Wu et al [12]. Genotyping of p73 exon 2 (rs2273953-rs1801173) was determined using DNA amplification, conducted as described by Niwa et al [25]. We conducted haplotype analysis for p53 intron 3, p53 exon 4 codon 72 and p53 intron 6 polymorphisms using EH software [34] and cocaphase [35]. Quality control for each genotyping was performed in each experiment, and 10% of the total samples were randomly selected and retested with 100% concordance. The analyst was blinded to the case or control status of the samples.
###end p 20
###begin title 21
Data Collection
###end title 21
###begin p 22
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 301 313 <span type="species:ncbi:9606">Participants</span>
###xml 838 850 <span type="species:ncbi:9606">Participants</span>
###xml 1320 1341 <span type="species:ncbi:10566">Human Papilloma Virus</span>
###xml 1343 1346 <span type="species:ncbi:10566">HPV</span>
A standard questionnaire was administered to cases and controls by trained medical doctors to elicit information on demographic variables, including cigarette smoking, drinking history, fruit and vegetable intake, physical activity, family history of cancer, and family history of SCCHN specifically. Participants were asked to focus on the year prior to diagnosis (for controls the year prior to the interview date) when answering questions regarding lifestyle. Pack-years were calculated as years smoked multiplied by the current number (or previous number, for those who had quit) of cigarettes smoked/day divided by 20. For quantification of fruit and vegetable intake, 70 grams was considered an average portion of vegetables (both fresh and cooked vegetables included) and 100 grams was considered an average portion of fruit [36]. Participants were classified as consuming >/= 2 portions/day if they regularly consumed at least one portion of fruit and one portion of vegetables per day or if they consumed at least 2 portions of fruit or 2 portions of vegetables per day. Cases were followed-up after histopathological diagnosis of cancer with a median follow-up time of 23 months (range 1-60 months), and information on recurrence of local and/or regional neck nodes was also recorded. Data concerning previous Human Papilloma Virus (HPV) infection were not available for either cases or controls as well as treatment practices adopted by cases.
###end p 22
###begin p 23
The proportion lost to follow-up among cases in the study cohort was 6.0%. The response rate for interview completion was 98.0% among cases and 96.0% among controls, with the exception of data relating to the family history of cancer (unknown in 22% of cases and 3.4% of controls), as well as the family history of oral cancer (unknown in 28.7% of cases and 3.4% of controls).
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 344 351 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
The relationship between SCCHN and putative risk factors were measured using the adjusted odds ratios (ORs) and their 95% confidence intervals (CI) derived from logistic regression analysis using STATA software (version 9). The SCCHN risk according to the 4 studied polymorphisms was estimated under the dominant model (variant allele carriers versus wild type allele homozygous). We considered possible risk factors for SCCHN as potential confounders if addition of that variable to the model changed the OR by 10% or more. Confounding checks were performed in both univariate and final multivariate models. If a factor was identified as a confounder of any estimated main effect, it was kept in all models. Based on these criteria, we controlled for gender, alcohol, pack-years of cigarette smoking, physical activity and fruit and vegetable intake. With exception of gender, we adjusted for confounders as continuous variables. After a logistic regression model has been fitted, the Hosmer-Lemeshow test was performed to assess the goodness of the model.
###end p 25
###begin p 26
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
We tested the relationship between the analyzed polymorphisms and tumour location (oral cavity, oropharynx, hypopharynx and larynx cancer) [3] by using a logistic multinomial regression analysis, using healthy controls as the reference group.
###end p 26
###begin p 27
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
The False Discovery Rate (FDR), which controls the expected proportion of false positives among a threshold given by the observed p-value distribution [37], was performed to correct for multiple comparisons resulting from association between the four polymorphisms and the different tumour locations.
###end p 27
###begin p 28
###xml 669 671 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 918 919 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 960 961 958 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Tests of Hardy Weinberg Equilibrium (HWE) were carried out for all of the polymorphisms among cases and controls separately . In order to examine if the effects of the studied polymorphisms are modified by selected environmental exposures and some other covariates, we performed a logistic regression analysis stratified by age, gender, alcohol, smoking status and family history of cancer. An homogeneity test was then used to test differences among the strata. In this analysis we used as a reference group those homozygous wild-type individuals who had not been exposed and confounders were considered as follows: age was categorized into </= 45 and > 45 years old [38], smoking status was considered as ever/never cigarette smokers, and alcohol consumption as drinkers/non-drinkers (the latter including individuals whose alcohol intake was less than 7 g/day). A gene-gene interaction analysis was performed among p73 G4C14-to-A4T14 polymorphism and three p53-SNPs in exon 4 and introns 3 and 6, and the likelihood ratio test was used to test for more than multiplicative effect among each pair of SNPs, with the homozygous wild-type individuals used as the reference group for each gene.
###end p 28
###begin p 29
###xml 152 159 <span type="species:ncbi:9606">patient</span>
Overall survival curves were calculated by the Kaplan-Meier product limit method from the date of diagnosis until progression of disease or death. If a patient was not dead, survival was censored at the time of the last visit. The log rank test was used to assess differences between subgroups. Disease Free Survival (DFS) was calculated from the day of histological diagnosis to the date of local recurrence of disease and/or regional lymph-node involvement. The risk of death and the risk of recurrence related to the studied polymorphisms were estimated by Cox's proportional hazards model. Hazard ratios (HR) were adjusted for age, gender, and stadium, with the wild-type genotypes as the reference group.
###end p 29
###begin title 30
Results
###end title 30
###begin p 31
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 926 927 926 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
General characteristics of the study population are presented in Table 1. The percentage of males was higher in cases then in controls (82.7% vs 60.0%; Table 1). Results show that alcohol consumption increases head and neck cancer risk, especially among heavy drinkers (OR = 18.56; 95% CI: 7.26-47.44). An increased risk was also detected for cigarette smokers, with an OR of 2.97 (95% CI: 1.72-5.12) and 8.23 (95% CI: 4.73-14.32) for 1-24 and > 24 pack-years of cigarettes smoked, respectively (Table 1). A low consumption of fruit and vegetables (< 2 portions/day) was significantly associated with SCCHN (OR = 2.70; 95% CI: 1.73-4.21). Additionally, family history of cancer was higher in cases than controls (OR = 2.42; 95% CI: 1.42-4.13), and even higher when considering the family history of SCCHN, although this is limited to a very small numbers of individuals (data not shown). Goodness of fit statistics provided a p-value > 0.42.
###end p 31
###begin p 32
Odds Ratios (95% Confidence Interval) for squamous cell carcinoma of the head and neck (SCCHN) according to the collected variables.
###end p 32
###begin p 33
* Reference group
###end p 33
###begin p 34
degrees Odds Ratio (OR) adjusted for gender, alcohol, pack-years, physical activity and fruit and vegetables intake
###end p 34
###begin p 35
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 536 538 536 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 708 709 708 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 810 812 810 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 825 827 823 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1125 1127 1123 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1146 1147 1144 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1237 1238 1235 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 1347 1349 1345 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1372 1373 1370 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1376 1377 1374 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1473 1474 1471 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1490 1491 1488 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1557 1558 1555 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 1561 1563 1559 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 790 797 <span type="species:ncbi:9606">patient</span>
###xml 1324 1332 <span type="species:ncbi:9606">patients</span>
The genotype frequencies of our control group were in line with those of Caucasians [39,40] and were in HWE for both cases and controls (p- value > 0.05). As shown in Table 2, the distribution of the studied polymorphisms was similar amongst the two groups. A significant association was observed between p73 variant allele carriers and cancer of the oral cavity (OR = 2.43; 95% CI: 1.23-4.81; p-value = 0.01), even if it didn't remain noteworthy after the FDR test correction because the statistically significant threshold was set at p = 0.0002. The estimated p53 pairwise haplotype frequencies among the three polymorphisms and their linkage disequilibrium values in cases and controls are shown in Table 3. The pairwise linkage disequilibria were highly significant in both control and patient population (p value for chi2 test < 0.001). The frequency of exon 4 (Pro)/intron 6 diplotype was lower in cases than in controls (12.1% versus 17.6%), with more than 30% reduced risk of SCCHN (OR = 0.67; 95% CI: 0.47-0.92). There were no significant differences in the remaining diplotype frequencies among cases and controls (p value > 0.1, Table 3). When the estimation of haplotype frequencies was extended to all the three SNPs (Table 4), results showed no significant difference in the haplotype frequencies among cancer patients and controls (p value > 0.1). From the p73-p53 gene-gene interaction analysis a more than additive effect was found for those carrying both p53 intron 3 and p73 variant alleles, with an OR of 2.22 (95% CI: 1.08-4.56) (Table 5) [41].
###end p 35
###begin p 36
Odds Ratios (95% CI) for head and neck cancer according to the studied polymorphisms
###end p 36
###begin p 37
* Reference group
###end p 37
###begin p 38
degrees OR adjusted for gender, alcohol, pack-years, physical activity and fruit and vegetables intake
###end p 38
###begin p 39
###xml 0 13 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167; </sup>
###xml 161 162 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
section sign This association (p-value = 0.01) didn't remain noteworthy after the FDR test correction because the statistically significant threshold was set at p-value = 0.0002.
###end p 39
###begin p 40
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Pairwise haplotype frequencies in SCCHN patients and controls.
###end p 40
###begin p 41
###xml 7 8 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 21 22 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
dagger p-value of chi2-test: cases versus controls > 0.1
###end p 41
###begin p 42
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
* p-value < 0.001
###end p 42
###begin p 43
double dagger 1 = intron 3 (W), exon 4 Arg, intron 6 G
###end p 43
###begin p 44
  2 = intron (M), exon 4 Pro, intron 6 A
###end p 44
###begin p 45
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Estimated p53 haplotype frequencies in SCCHN patients and controls.
###end p 45
###begin p 46
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 14 15 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
p-value of chi2-test: cases versus controls > 0.1
###end p 46
###begin p 47
double dagger 1 = intron 3 (W), exon 4 Arg, intron 6 G
###end p 47
###begin p 48
  2 = intron (M), exon 4 Pro, intron 6 A
###end p 48
###begin p 49
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Adjusted Odds Ratios (95% CI) of SCCHN for the p73 exon 2 G4A- p53 interaction analysis.
###end p 49
###begin p 50
* = Reference category
###end p 50
###begin p 51
dagger = By likelihood ratio test
###end p 51
###begin p 52
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus </italic>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 580 582 580 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 691 692 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 812 814 812 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
From our analysis there was no evidence of effect modification of the four SNPs by the environmental exposures (data not shown). Age was an effect modifier of the association between p73 exon 2 and SCCHN [OR = 12.85 (95% CI: 2.10-78.74) in individuals younger than 45 years versus an OR = 1.19 (95% CI: 0.72-1.96) in individuals older than 45 years (p value of homogeneity among the estimates = 0.013)]. In addition, current smokers carrying the variant allele of p73 exon 2 had an OR of 3.60 (95% CI: 1.30-9.92) for SCCHN, while never smokers an OR of 1.32 (95% CI: 0.80 - 2.19; p value of heterogeneity among strata estimates = 0.10). Lastly, female smokers carrying the variant allele of p73 exon 2 had an OR of 4.18 (95% CI: 0.92-19.02) for SCCHN versus an OR of 1.07 (95% CI: 0.54-2.14) among smoker males (p value of homogeneity = 0.10).
###end p 52
###begin p 53
###xml 445 446 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 537 538 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
Overall actuarial 2-year survival rate was 84.4% (95% CI: 79.7-88.2) with a 2-year DFS rate of 81.2% (95% CI: 76.2-85.3). During the follow-up period local recurrence was observed in 53 cases, among them five patients also experienced metastatic regional lymph-node involvement. The survival analysis showed no significant association between any of the polymorphisms, overall survival and DFS (data not shown), even though individuals carrying p53 intron 6 variant allele had an HR for the overall survival of 0.51 (95% CI: 0.23-1.16) (p-value for log-rank test = 0.05) (Figure 1).
###end p 53
###begin p 54
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Association between <italic>p </italic>53 intron 6 and overall survival among 283 SCCHN cases</bold>
Association between p 53 intron 6 and overall survival among 283 SCCHN cases.
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 393 394 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 688 689 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1019 1020 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1169 1170 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1253 1255 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1300 1301 1300 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 786 793 <span type="species:ncbi:9606">persons</span>
This case-control study evaluated the effect of four polymorphisms in the p53 and p73 genes on the risk of squamous cell carcinoma of the head and neck in an Italian population. To our knowledge, our's is the first study reporting an increased risk of SCCHN among individuals with combined p73 exon 2 G4A and p53 intron 6 variant alleles and a protective effect for those carrying p53 exon 4- p53 intron 6 diplotype combination. Additionally, we showed that p73 exon 2 G4A variant allele increases the risk of cancer of the oral cavity, which is in line with the results of Li et al [10]. From the gene-environment interaction analysis we showed that individuals aged < 45 years carrying p73 exon 2 G4A variant allele have 12.85-times significant increased risk for SCCHN compared with persons of the same age with the homozygous wild type genotype. Even though this observation stems from a subgroup made up of less than 100 individuals, it confirms the results of Li et al [10]. The absence of an association between p53 exon 4 and SCCHN confirms the results of three published studies among Caucasians [13-15], while the absence of a significant association between p53 introns 3 and 6 and SCCHN is in line with the results of other tumour sites [42,43]. Lastly, carriers of the variant allele of p53 intron 6 showed a poorer prognosis following cancer diagnosis.
###end p 56
###begin p 57
###xml 127 139 127 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a posterior </italic>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1004 1007 <span type="species:ncbi:10566">HPV</span>
In interpretation of our results some limitations of the study should be taken into account. Firstly, given the results of our a posterior power calculation on the basis of the prevalence of the analyzed polymorphisms in our control population, our study is powered to detect a minimum OR of 2.0 for the effect of variant allele carriers for all studied polymorphisms (with a significance level of 5%). The study's sample size limits the possibility to explore the combined effects of the genotypes, or gene-environment interactions, thus we need to increase the sample size in order to confirm our results. However, when appropriately conducted, large and small studies should theoretically give the same results, but with a more precise effect measure estimate in the larger ones [44]. Secondly, as in all case-control studies, information bias may exist, leading to biased ORs of the effects of lifestyle and environmental exposures, alone or in combination with a gene polymorphism. Thirdly, data on HPV infection were unavailable in our study population.
###end p 57
###begin p 58
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 578 579 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 963 972 963 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1086 1087 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Our study reports for the first time an increased risk of SCCHN in individuals carrying both p73 exon 2 and p53 intron 3 unfavourable variants. Taking into account all the possible combinations of p73 exon 2 and p53 intron 3 alleles, the large study Schabath et al. [22] recently reported a 13% increased risk of lung cancer for individuals carrying every additional variant allele, however they did not differentiate among variant alleles. We did not report any effect for the remaining p73-p53 gene-gene interactions, thus confirming the results from Niwa et al on p73 exon 2-p53 exon 2 and endometrial cancer [25]. The results of the p53 haplotype analysis and SCCHN show that individuals carrying combined unfavourable variants of p53 exon 4 and intron 6 are protected from SCCHN, and these results are in line with those reported for lung, breast and gastric cancer [12,45,46]. Due the potential application of these results in cancer prevention, additional in vitro studies are urgently required to clarify the mechanism through which the combined effect of these strongly linked p53 SNPs might influence the protein function.
###end p 58
###begin p 59
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p73 </italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p73 </italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 713 714 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 994 995 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1109 1113 1109 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p73 </italic>
###xml 1393 1397 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p73 </italic>
###xml 1508 1510 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 879 884 <span type="species:ncbi:9606">women</span>
###xml 945 948 <span type="species:ncbi:9606">men</span>
###xml 975 980 <span type="species:ncbi:9606">women</span>
Our study shows that p73 exon 2 G4C14-to-A4T14 polymorphism increases the risk of cancer of the oral cavity, even though the result is no longer significant after correction for multiple testing. This is in line, however, with results from Li et al [10], and for other tumour sites such as colorectal, oesophageal, and gastric cancer among Caucasians [10,24,32]. Additionally, p73 exon 2 G4C14-to-A4T14 polymorphism seems to increase the risk of SCCHN particularly among individuals younger than 45, where the genetic susceptibility usually plays a major role in the early onset of SCCHN with respect to the environmental exposures [24]. Lastly, gender appears to be an effect modifier of the association between p73 AT variant allele and SCCHN, with female smokers at an increased risk compared to males, as reported from Li et al. [10]. Based on previous findings showing that women tend to have a lower capacity of DNA repair with respect to men [26], it is possible that women carrying the p73 G4C14-to-A4T14 variant allele are more sensitive to carcinogens. In order to confirm the potential role of the p73 G4C14-to-A4T14 polymorphism on SCCHN, however, further studies on its functional effect are needed. Since this polymorphic site is located in a non coding region it remains to be explained how the variant allele can modulate the protein function. Also, it should be verified that p73 G4C14-to-A4T14 does not exists in linkage disequilibrium with functional alleles at other susceptibility loci [24].
###end p 59
###begin p 60
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 505 513 <span type="species:ncbi:9606">patients</span>
###xml 620 626 <span type="species:ncbi:9606">people</span>
The results of the present study shows a decreased mortality rate for individuals carrying the variant allele of p53 intron 6 compared with the wild-type genotype. A similar result has been reported for the intestinal histotype of gastric cancer (De Feo et al. A case-control study on the effect of p53 and p73 polymorphisms on gastric cancer risk and progression in an Italian population. 'Mutation Research, Genetic Toxicology and Environmental Mutagenesis', in press) and chronic lymphocitic leukaemia patients when considering the time of treatment-free survival as the main outcome [45]. Due to the small number of people involved in the survival anlaysis, however, further research should confirm our preliminary evidence.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
###xml 78 79 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Our study provides for the first time evidence that individuals carrying both p53 exon 4 and p53 intron 6 variant allels are significantly protected against SCCHN, while an additional risk is conferred by the combination of p73 exon 2 G4C14-to-A4T14 and p53 intron 3 variant alleles. We confirm the existing evidence that p73 exon 2 G4C14-to-A4T14 increases the risk of oral cavity cancer. Larger prospective studies are needed to further confirm our results.
###end p 62
###begin title 63
Abbreviations
###end title 63
###begin p 64
CI: Confidence Interval; DFS: Disease Free Survival; HR: Hazard Ratio; HWE: Hardy-Weinberg Equilibrium; OR: Odds Ratio; PCR: Polymerase Chain Reaction; SCCHN: Squamous Cell Carcinoma of the Head and Neck; SNP: Single Nucleotide Polymorphism.; FDR: False Discovery Rate.
###end p 64
###begin title 65
Competing interests
###end title 65
###begin p 66
The authors declare that they have no competing interests.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
###xml 247 255 <span type="species:ncbi:9606">patients</span>
SB and GR conceived the study and coordinated the research group; PG, EDF and SB performed the statistical analysis and drafted the manuscript; DA and RA carried out the genotyping; GC, MV, AG and GP participated in the study design, enrolled the patients and interviewed them.
###end p 68
###begin title 69
Pre-publication history
###end title 69
###begin p 70
The pre-publication history for this paper can be accessed here:
###end p 70
###begin p 71

###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
This research paper has been supported by a grant from Universita Cattolica del Sacro Cuore (D1 projects 2008).
###end p 73
###begin p 74
We are grateful to Alessandra Ronconi, Giacomina Chiaradia, Antonella Sferrazza for the statistical review, and Jessica Rowell for the linguistic revision of the final manuscript.
###end p 74
###begin article-title 75
Estimates of the worldwide mortality from 25 cancers in 1990
###end article-title 75
###begin article-title 76
Alcohol consumption and risk of laryngeal cancer
###end article-title 76
###begin article-title 77
###xml 16 23 <span type="species:ncbi:4097">tobacco</span>
Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe
###end article-title 77
###begin article-title 78
###xml 8 28 <span type="species:ncbi:10566">human papillomavirus</span>
Role of human papillomavirus in the etiology of head and neck cancer
###end article-title 78
###begin article-title 79
CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer
###end article-title 79
###begin article-title 80
Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies
###end article-title 80
###begin article-title 81
Genetic mechanisms in squamous cell carcinoma of the head and neck
###end article-title 81
###begin article-title 82
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Surfing the p53 network
###end article-title 82
###begin article-title 83
TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis
###end article-title 83
###begin article-title 84
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck
###end article-title 84
###begin article-title 85
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan
###end article-title 85
###begin article-title 86
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity
###end article-title 86
###begin article-title 87
Genetic polymorphisms in head and neck cancer risk
###end article-title 87
###begin article-title 88
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck
###end article-title 88
###begin article-title 89
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study
###end article-title 89
###begin article-title 90
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma
###end article-title 90
###begin article-title 91
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
###end article-title 91
###begin article-title 92
Genetic variation in TP53 and risk of breast cancer in a population-based case control study
###end article-title 92
###begin article-title 93
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
p53 mutations in matched primary and metastatic human tumors
###end article-title 93
###begin article-title 94
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma
###end article-title 94
###begin article-title 95
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 99 104 <span type="species:ncbi:9606">human</span>
Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers
###end article-title 95
###begin article-title 96
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Combined effects of the p53 and 73 polymorphisms on lung cancer risk
###end article-title 96
###begin article-title 97
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
###end article-title 97
###begin article-title 98
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
p73 G4C14-to-A4T14 polymorphism and risk of lung cancer
###end article-title 98
###begin article-title 99
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects
###end article-title 99
###begin article-title 100
###xml 9 10 9 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma
###end article-title 100
###begin article-title 101
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population
###end article-title 101
###begin article-title 102
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
###end article-title 102
###begin article-title 103
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis
###end article-title 103
###begin article-title 104
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Genotype phenotype correlations in Israeli colorectal cancer patients
###end article-title 104
###begin article-title 105
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
###end article-title 105
###begin article-title 106
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Polymorphism of the p73 gene in relation to colorectal cancer risk and survival
###end article-title 106
###begin article-title 107
A new statistical method for haplotype reconstruction from population data
###end article-title 107
###begin article-title 108
Is 'five-a-day' an effective way of increasing fruit and vegetable intakes?
###end article-title 108
###begin article-title 109
Controlling the false discovery rate: a practical and powerful approach to multiple testing
###end article-title 109
###begin article-title 110
###xml 69 75 <span type="species:ncbi:9606">people</span>
Risk factors for squamous cell carcinoma of the oral cavity in young people: a comprehensive literature review
###end article-title 110
###begin article-title 111
Perspectives on the molecular epidemiology of aerodigestive tract cancers
###end article-title 111
###begin article-title 112
Metabolic gene polymorphism frequencies in control populations
###end article-title 112
###begin article-title 113
###xml 19 20 19 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 51 58 <span type="species:ncbi:4097">tobacco</span>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Risk assessment of p53 genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern India
###end article-title 113
###begin article-title 114
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
p53 genotypes and haplotypes associated with risk of breast cancer
###end article-title 114
###begin article-title 115
Meta-analysis in public health: potential and problems
###end article-title 115
###begin article-title 116
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia
###end article-title 116

